Low-dose aspirin therapy in obstetrics.
The results of four large controlled clinical trials, encompassing over 13,000 pregnant women, indicate that low-dose aspirin is of benefit in the prevention of pre-eclampsia in women at high risk. The preventive effect on fetal growth retardation seems to be small, and no therapeutic benefits could be established. Low-dose aspirin appears to be safe for mother, fetus, and neonate.
Wallenburg
H C
HC
Institute of Obstetrics and Gynecology, Erasmus University Medical School, Rotterdam, The Netherlands.
D001241:Aspirin / Q000008:administration & dosage*; D005260:Female; D005317:Fetal Growth Retardation / Q000517:prevention & control*; D006801:Humans; D011225:Pre-Eclampsia / Q000517:prevention & control*; D011247:Pregnancy; D016032:Randomized Controlled Trials as Topic
D001241:Aspirin